Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma

Clinical trial NCT07453446 · WITHDRAWN

Trial details

NCT number: NCT07453446
Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Lymphoma

Start date: 2025-03-04
Primary completion: 2027-03-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.